VERIFIEDMint Markets·5d★ ON YOUR LIST☆Gland Pharma to Biocon: Pharma stocks rally up to 27% in a month: Can they shield portfolio from US-Iran war-led risks?AI summary· POSITIVE·The Nifty Pharma index has risen by approximately 11% in the last month.·The Nifty Pharma index has outperformed the Nifty 50, which saw a 3.6% decline in the same period.·Year-to-date, the Nifty Pharma index has gained 9.4%, while the Nifty 50 has fallen by an equal margin.BIOCONNIFTYNIFTYPHARMAGLAND
VERIFIEDET Stocks·5d★ ON YOUR LIST☆Cenexi recovery, new product launches and capacity additions power Gland Pharma outlookAI summary· POSITIVE·Gland Pharma's stock reached a 52-week high after strong March quarter and full-year financial results.·The company's European subsidiary, Cenexi, is showing improved profitability.·Future growth is expected from capacity expansions, new product launches, and an expanding contract development and manufacturing business.GLAND
VERIFIEDET Markets·8d★ ON YOUR LIST☆Gland Pharma,6 stocks hit 52-week highs, rally up to 20% in a monthAI summary· NEUTRALGLAND
VERIFIEDET Stocks·8d★ ON YOUR LIST☆Gland Pharma,6 stocks hit 52-week highs, rally up to 20% in a monthAI summary· POSITIVE·Gland Pharma is among the stocks that have reached a 52-week high.·Several stocks have hit their 52-week highs.·These stocks have seen rallies of up to 20% in the past month.GLAND
REFERENCEGoogle News, India stocks·8d★ ON YOUR LIST☆Sensex Today Ends Marginally Higher | Nifty Above 23,600 | Gland Pharma Up 15% - EquitymasterSummarize with AI →NIFTYSENSEXGLAND
VERIFIEDMint Markets·8d★ ON YOUR LIST☆Top Gainers & Losers on May 18: Gland Pharma, Coforge, PB Fintech, BSE, Voltas, Bharti Airtel among top gainersAI summary· NEUTRALCOFORGEBHARTIARTLVOLTASNIFTYSENSEXGLANDPOLICYBZR
REFERENCEGoogle News, NIFTY/SENSEX·8d★ ON YOUR LIST☆Gland Pharma, NCC, Vi, Amber Enterprises among buzzing stocks as SENSEX, NIFTY50 trade flat - UpstoxSummarize with AI →NIFTYSENSEXGLAND
VERIFIEDET Stocks·8d★ ON YOUR LIST☆Gland Pharma shares jump 11% as Q4 profit soars 97% YoY, co announces Rs 20/share final dividendAI summary· POSITIVE·Gland Pharma's Q4 profit increased by 97% year-on-year.·The company reported strong revenue growth driven by its CDMO business.·A final dividend of ₹20 per share for FY26 was announced.GLAND
VERIFIEDMint Markets·8d★ ON YOUR LIST☆Gland Pharma share price jumps over 16% to 52-week high despite stock market crash. Should you buy the pharma stock?AI summary· POSITIVE·Gland Pharma share price jumped over 16% to a 52-week high.·The pharma stock has rallied 17% in the past month.·Gland Pharma has gained 22% on a year-to-date basis.GLAND